Nimodipine
Antihypertensive (calcium channel blocker)
- Mania/mixed
- Bipolar Anxiety
- May work like lithium
- Ultra-rapid cycling
- SE-tremor
- Vascular Depression
Features
Dosing
Bipolar: Start 30 mg TID, raise by 15 mg every 10 days to target of 240-480 mg/day, divided TID
Vascular depression: Start 30 mg TID, raise by 15 mg every 10 days to target of 90 mg TID
Tremor: 30 mg qid
INTERACTIONS: CYP3A4 inducers/inhibitors alter its levels (including grapefruit which raises it). Levels 2x higher in elderly. FOOD: Do not take within 1 hr of meal (food lowers levels by 30-50%).
SHORT HALF-LIFE: 1-2 hr. Generic but expensive.
Management
Possibly treats mania, rapid cycling (4 episodes per year), ultra-rapid cycling (more frequent), and bipolar-anxiety. Similar to isradipine and amlodipine, while verapamil has a different mechanism.
Treats vascular depression through calcium-signalling and improving vascular flow.
TOLERABILITY: Dizziness, GI upset, rare edema.
RISKS: Get medical approval in heart disease (AV conduction delays). Monitor BP (hypotension risk). Very rare LFT elevation.
EMR Text
Bipolar Rapid Cycling
Nimodipine use based on trials in rapid/ultra-rapid cycling bipolar disorder (Pazzaglia PJ et al,Psychiatry Res. 1993;49(3):257-272)
Off label use and cardiac risks (hypotension) reviewed with patient
Vascular Depression
Nimodipine use based on controlled trials in vascular depression (Taragano FE et al, Int Psychogeriatr. 2005;17(3):487-498).
Off label use and cardiac risks (hypotension) reviewed with patient
Tremor
Nimodipine use based on controlled trial in tremor (Taragano FE et al, Int Psychogeriatr. 2005;17(3):487-498).
Off label use and cardiac risks (hypotension) reviewed with patient